Literature DB >> 16453180

Expression of beta defensins in ocular surface tissue of experimentally developed allergic conjunctivitis mouse model.

Ai Ikeda1, Yoko Nakanishi, Tohru Sakimoto, Jun Shoji, Mitsuru Sawa, Norimichi Nemoto.   

Abstract

PURPOSE: To investigate the expression of beta-defensin in the ocular surface of a mouse experimental allergic conjunctivitis (EAC) model.
METHODS: Mouse beta-defensin (mBD)-1 and -2 mRNA expressed in conjunctival tissue of both the EAC and the control group were analyzed by real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. mBD-1 and mBD-2 mRNA expressed in cornea, limbus, and conjunctival epithelium of the EAC and the control group were also analyzed using a laser-assisted microdissection technique and the RT-PCR method.
RESULTS: There was no significant difference in the amount of mBD-1 between the EAC and the control group. However, the EAC group had significantly less mBD-2 (0.23 +/- 0.15 x 10(4) copy/microl) than the control group (3.61 +/- 4.87 x 10(4) copy/microl) (P < 0.01, Mann-Whitney U test). mBD-1 mRNA was positive for all examined tissue in both groups. The expression of mBD-2 mRNA in the EAC group was definitely positive for the corneal and conjunctival epithelium and negative for the limbus.
CONCLUSION: mBD-2 mRNA was expressed significantly less in the EAC model than in the control. Analysis by site in the ocular surface tissue revealed that this reduction was caused by the diminished expression of mBD-2 in the limbus. Copyright Japanese Ophthalmological Society 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16453180     DOI: 10.1007/s10384-005-0262-4

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  31 in total

1.  Ocular surface epithelia express mRNA for human beta defensin-2.

Authors:  N A McNAMARA; R Van; O S Tuchin; S M Fleiszig
Journal:  Exp Eye Res       Date:  1999-11       Impact factor: 3.467

2.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

3.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.

Authors:  E V Valore; C H Park; A J Quayle; K R Wiles; P B McCray; T Ganz
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  A novel murine beta -defensin expressed in tongue, esophagus, and trachea.

Authors:  H P Jia; S A Wowk; B C Schutte; S K Lee; A Vivado; B F Tack; C L Bevins; P B McCray
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

5.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

6.  Expression of human beta-defensins in conjunctival epithelium: relevance to dry eye disease.

Authors:  Srihari Narayanan; William L Miller; Alison M McDermott
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

7.  Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel.

Authors:  D E Jones; C L Bevins
Journal:  FEBS Lett       Date:  1993-01-04       Impact factor: 4.124

8.  Identification on mouse chromosome 8 of new beta-defensin genes with regionally specific expression in the male reproductive organ.

Authors:  Angel Zaballos; Ricardo Villares; Juan Pablo Albar; Carlos Martínez-A; Gabriel Márquez
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

9.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice.

Authors:  Yasuhiro Yamaguchi; Takahide Nagase; Ryosuke Makita; Shigetomo Fukuhara; Tetsuji Tomita; Takashi Tominaga; Hiroki Kurihara; Yasuyoshi Ouchi
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  3 in total

Review 1.  Host-pathogen interactions in the cornea.

Authors:  Takashi Suzuki; Ai Yamada; Michael S Gilmore
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

Review 2.  Role of host-defence peptides in eye diseases.

Authors:  Satya S Kolar; Alison M McDermott
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

Review 3.  Host Defense Peptides at the Ocular Surface: Roles in Health and Major Diseases, and Therapeutic Potentials.

Authors:  Darren Shu Jeng Ting; Imran Mohammed; Rajamani Lakshminarayanan; Roger W Beuerman; Harminder S Dua
Journal:  Front Med (Lausanne)       Date:  2022-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.